不可切除的三阴性乳腺癌的临床试验
总计3103个结果
-
Novartis Pharmaceuticals撤销
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC完全的
-
Washington University School of MedicineBristol-Myers Squibb主动,不招人
-
Canadian Cancer Trials GroupUniversity Health Network, Toronto; AstraZeneca主动,不招人
-
The Netherlands Cancer InstituteBristol-Myers Squibb主动,不招人
-
Georgetown UniversityBristol-Myers Squibb主动,不招人
-
University of Wisconsin, MadisonThe V Foundation for Cancer Research终止
-
Cedars-Sinai Medical CenterAstraZeneca撤销
-
ImmunityBio, Inc.撤销
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Susan G. Komen Breast Cancer Foundation完全的
-
AZ-VUBUniversitaire Ziekenhuizen KU Leuven; Universitair Ziekenhuis Brussel完全的
-
Massachusetts General HospitalNational Cancer Institute (NCI); Federal Share Core撤销
-
Ottawa Hospital Research Institute完全的
-
Cancer Institute and Hospital, Chinese Academy...未知
-
PfizerAstellas Pharma Inc; Medivation, Inc.撤销
-
Genentech, Inc.SOLTI Breast Cancer Research Group完全的
-
Mario Negri Institute for Pharmacological Research终止
-
CASI Pharmaceuticals, Inc.University of Colorado, Denver; Indiana University Melvin and Bren Simon Cancer Center完全的
-
SanofiBreast Cancer Research Foundation完全的
-
Russian Academy of Medical SciencesRussian Society of Clinical Oncology未知
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)撤销
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)完全的IV 期乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性 | HER2/Neu 阴性 | 孕激素受体阴性 | 三阴性乳腺癌美国
-
Genexine, Inc.Merck Sharp & Dohme LLC完全的
-
Columbia UniversityWyeth is now a wholly owned subsidiary of Pfizer; Genentech, Inc.完全的
-
Fudan University招聘中乳腺癌 | 乳腺肿瘤 | 乳腺肿瘤 | HER2阳性乳腺癌 | 局部晚期乳腺癌 | HER2 阴性乳腺癌 | 激素受体阳性肿瘤 | 激素受体阴性肿瘤 | 早期乳腺癌 | 三阴性乳腺癌 (TNBC)中国
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.主动,不招人
-
CytomX Therapeutics完全的肿瘤 | 乳腺癌 | 乳腺肿瘤 | 乳腺肿瘤,三阴性 | 乳腺肿瘤,激素受体阳性/HER2 阴性美国, 西班牙, 大韩民国